about
Diverse Roles of Heparan Sulfate and Heparin in Wound RepairBee pollen: chemical composition and therapeutic applicationPropolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healingLaboratory Indicators of Aggrecan Turnover in Juvenile Idiopathic Arthritis.Propolis induces chondroitin/dermatan sulphate and hyaluronic Acid accumulation in the skin of burned wound.Positive effect of propolis on free radicals in burn wounds.Microwave Saturation of Complex EPR Spectra and Free Radicals of Burnt Skin Treated with Apitherapeutic Agent.Influence of Temperature on Free Radical Generation in Propolis-Containing OintmentsPlasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.Propolis modulates fibronectin expression in the matrix of thermal injury.Application of Numerical Analysis of the Shape of Electron Paramagnetic Resonance Spectra for Determination of the Number of Different Groups of Radicals in the Burn Wounds.The role of the extracellular matrix components in cutaneous wound healing.Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis.Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy.Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic controlAge- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 levelAlterations in serum glycosaminoglycan profiles in Graves' patientsAge- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageingPlasma biomarkers of oxidative and AGE-mediated damage of proteins and glycosaminoglycans during healthy ageing: a possible association with ECM metabolismAntioxidant activity and structural modifications of serum chondroitin sulfate in Graves' diseaseInteractions of short-acting, intermediate-acting and pre-mixed human insulins with free radicals--Comparative EPR examinationAlterations of plasma glycosaminoglycan profile in patients with rheumatoid arthritis in relation to disease activityCirculating keratan sulfate as a marker of metabolic changes of cartilage proteoglycan in juvenile idiopathic arthritis; influence of growth factors as well as proteolytic and prooxidative agents on aggrecan alterationsUrinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent populationEPR Spectroscopic Examination of Different Types of Paramagnetic Centers in the Blood in the Course of Burn HealingCirculating C1q/TNF-Related Protein 3, Omentin-1 and NGAL in Obese Patients with Type 2 Diabetes During Insulin TherapySignificant Remodeling Affects the Circulating Glycosaminoglycan Profile in Adult Patients with both Severe and Mild Forms of Acute PancreatitisPlasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta
P50
Q26799832-4DA2E3D1-1627-4F5E-AB3D-8E318CC89E04Q26863691-195A6909-C1F6-49AB-B4FA-8941BB0CC472Q36386289-4C4481DD-24A2-486C-B242-E7C769B6FEB7Q36564656-91F90C82-5787-4964-AF9B-D73371C30909Q36711687-37BC35F5-8119-4DFB-96AE-C65E419FE3FFQ36914134-591BCD76-81D0-40A2-950D-0109567F4E95Q36918407-B9342407-4B9F-4C55-A116-C576BFA898C9Q37181095-1FF7D3D4-84CD-4164-9624-37EFEF9F9CE5Q41432726-809A378A-982E-44DC-A744-3214F287D666Q42130664-5FDF3E85-1870-4ADA-B0BC-4A7D8F01A34FQ42262200-C142A264-86B4-4A21-A711-7957AD51E082Q42373904-E1658A5E-4D41-4699-8496-18FB51C43BE9Q46936552-17B9C3FA-412F-41D0-A44C-85B9DDEDF9B5Q51554149-66F47EB1-5FB5-4A58-ABAC-C07BE54DF942Q55501346-B4389416-A0F0-469D-BE59-E22BB6A98473Q81244047-D03E6E93-8CCB-48BC-9883-BCF4392B515DQ83161416-6FA01D8C-A150-4EF2-BDF6-A94CEB223CDAQ83302203-5E06A105-EC7C-4344-905A-631ACF70C2D9Q83896697-81D3C9FA-F0BC-4975-B24A-3E829DADD8E2Q84589590-B283B000-C56B-4423-86E9-ECB3DEE5B02BQ87271039-CB16C4C2-C03E-4E7B-907F-231C0348B5B2Q87310946-72B26A97-D930-49CA-B3D2-9C5BDD98AD1DQ87414607-E6C56970-A4C7-435D-9B07-E8CC227BABCDQ87651023-9650C506-6B0D-4068-8610-58B7CFC6B5E8Q88135569-1D53C4A2-2F86-402D-8D75-59CE96C6B7A3Q92005515-E7F7E3CD-4579-40CF-B589-981314C36566Q92724352-8BA2CED7-8129-4DB5-AEA8-83835BECD977Q94543550-65CC378A-9B30-4DBB-98A6-0E0AFFB198A3Q94554113-4D54A2E6-39E3-43F9-8C3A-B39999477C43
P50
description
researcher
@en
wetenschapper
@nl
name
K Komosinska-Vassev
@en
K Komosinska-Vassev
@nl
type
label
K Komosinska-Vassev
@en
K Komosinska-Vassev
@nl
prefLabel
K Komosinska-Vassev
@en
K Komosinska-Vassev
@nl
P106
P31
P496
0000-0003-2307-5884